跳至主要内容
临床试验/EUCTR2005-001010-41-IT
EUCTR2005-001010-41-IT进行中(未招募)不适用

An outpatient, randomised, double-blind, placebo controlled, parallel group exploratory study to evaluate safety, tolerability and efficacy of GW679769 in patients with Fibromyalgia syndrome comorbid with depression.

GLAXO SMITHKLINE0 个研究点目标入组 50 人开始时间: 2006年1月3日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
1 期
Does a long term tokolysis with atosiban provide any benefit for the pregnancy outcome, compared to the standard short term tokolysis?Premature uterine contractionspremature laborMedDRA version: 16.1Level: LLTClassification code 10068718Term: Premature uterine contractionsSystem Organ Class: 100000004868MedDRA version: 16.1Level: LLTClassification code 10036599Term: Premature laborSystem Organ Class: 100000004868
EUCTR2013-002561-19-ATMedizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Geburtshilfe und Feto-maternale Medizin60
进行中(未招募)
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyumbosacral radiculopathy
EUCTR2019-002632-90-PLOlainfarm AS458
进行中(未招募)
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathy
EUCTR2019-002632-90-LVOlainfarm AS458
进行中(未招募)
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyumbosacral radiculopathy
EUCTR2019-002632-90-CZOlainfarm AS458
已完成
3 期
A double-blind, randomised, placebo-controlled study to evaluate the effect of an orally-dosed herbal extract, Testofen, for the treatment of Benign Prostatic Hyperplasia (BPH) symptoms in otherwise healthy males.
ACTRN12615001242516Amanda Rao100
An outpatient, randomised, double-blind, placebo... | 临床试验